Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.82 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.67 |
| ▸ | DGKA | P23743 | 2/20 | 0.65 |
| ▸ | CNR2 | P34972 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10529166 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL3657147 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL324737 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL93861 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL15664437 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL29454638 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL10715660 | 1.00 | MGLL (0.82) | MGLLEPHX2DGKACNR2MAPT | |
| SCHEMBL10491614 | 0.98 | MGLL (0.80) | MGLLEPHX2DGKACNR2MAPT | |
| Ethylene SCHEMBL11081375 | 0.97 | MGLL (0.78) | MGLLEPHX2DGKACNR2MAPT | |
| Ethylene SCHEMBL5314467 | 0.97 | MGLL (0.78) | MGLLEPHX2DGKACNR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207408-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2024-06-27 | — | — | US | disclosed |
| US-11992555-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2024-05-28 | — | — | US | disclosed |
| US-11918654-B2 | Solid solution compositions and use in severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2024-03-05 | — | — | US | disclosed |
| US-11844773-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2023-12-19 | — | — | US | disclosed |
| US-11826428-B2 | Solid solution compositions comprising cannabidiols | INFIRST HEALTHCARE LIMITED (GB) | 2023-11-28 | — | — | US | disclosed |
| US-11730709-B2 | Compositions and methods for treating severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2023-08-22 | — | — | US | disclosed |
| US-20220118091-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2022-04-21 | — | — | US | disclosed |
| US-11224659-B2 | Solid solution compositions and use in severe pain | INFIRST HEALTHCARE LIMITED (GB) | 2022-01-18 | — | — | US | disclosed |
| US-11202831-B2 | Solid solution compositions and use in cardiovascular disease | INFIRST HEALTHCARE LIMITED (GB) | 2021-12-21 | — | — | US | disclosed |
| US-11154500-B2 | Solid solution compositions and use in chronic inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2021-10-26 | — | — | US | disclosed |
| WO-2014108569-A1 | COMPOSITIONS AND METHODS FOR TREATING SEVERE PAIN | BIOCOPEA LIMITED (GB) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014108572-A1 | SOLID SOLUTION COMPOSITIONS AND USE IN CARDIOVASCULAR DISEASE | BIOCOPEA LIMITED (GB) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014108573-A1 | SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | BIOCOPEA LIMITED (GB) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014108574-A1 | SOLID SOLUTION COMPOSITIONS AND USE IN SEVERE PAIN | BIOCOPEA LIMITED (GB) | 2014-07-17 | — | — | WO | disclosed |
| WO-2014108571-A2 | CANCER DRUG AND USES | BIOCOPEA LIMITED (GB) | 2014-07-17 | — | — | WO | disclosed |
| US-20140162988-A1 | Solid Solution Compositions and Use in Chronic Inflammation | BIOCOPEA LIMITED (GB) | 2014-06-12 | — | — | US | disclosed |
| US-20140162987-A1 | Solid Solution Compositions and Use in Severe Pain | BIOCOPEA LIMITED (GB) | 2014-06-12 | — | — | US | disclosed |
| US-20140155485-A1 | Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases | BIOCOPEA LIMITED (GB) | 2014-06-05 | — | — | US | disclosed |
| US-20140128353-A1 | Solid Solution Compositions and Use in Cardiovascular Disease | BIOCOPEA LIMITED (GB) | 2014-05-08 | — | — | US | disclosed |
| US-20140128354-A1 | Compositions and Methods for Treating Severe Pain | BIOCOPEA LIMITED (GB) | 2014-05-08 | — | — | US | disclosed |